VIRAL LOAD MONITORING – HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) - ANVISA Registration 81062710054

Access comprehensive regulatory information for VIRAL LOAD MONITORING – HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81062710054 and manufactured by manufacturer not specified. The registration is held by Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltda with validity until Aug 07, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT MOLECULAR INC., ELITECH GROUP S.P.A, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81062710054
2 Related Devices
Registration Details
ANVISA Registration Number: 81062710054
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

81062710054

25351353841202281

18628083000123

Dates and Status

Aug 07, 2023

07/08/2033

09/18/2025 19:00:01

Registration Details

81062710054

25351353841202281

18628083000123

Company Information

CEPHEID AB
Sweden
PT: SUÉCIA

Dates and Status

Aug 07, 2023

07/08/2033

09/18/2025 19:00:01